Concepedia

Publication | Open Access

Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis

10

Citations

0

References

2019

Year

Abstract

The studies identify the acid sphingomyelinase as a novel therapeutic target for treating MS patients.